Skip to main content
SpringerLink
Log in
Book cover

Renal Cell Carcinoma pp 79–92Cite as

Molecular Genetics of Renal Cell Carcinoma

  • Chapter

  • 126 Accesses

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Renal cancer is diagnosed in about 28,800 Americans each year, and is responsible for more than 11,300 deaths per year (1). Renal cancer is most commonly diagnosed between the age of 50 and 70, and affects men twice as frequently as women (2). Environmental factors linked to the development of renal cancer include cigarette smoking, obesity, and exposure to asbestos, cadmium, or petrochemical products (3–8).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parker SL, Tong T, Bolden S, and Wingo PA. Cancer statistics, CA. Cancer J. Clin., 47 (1997) 5–27.

    Article  CAS  PubMed  Google Scholar 

  2. Linehan WM, Lerman MI, and Zbar B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer, JAMA, 273 (1995) 564–570.

    Article  CAS  PubMed  Google Scholar 

  3. La Vecchia C, Negri E, D’Avanzo B, and Franceschi S. Smoking and renal cell carcinoma, Cancer Res., 50 (1990) 5231–5233.

    PubMed  Google Scholar 

  4. McCredie M and Stewart JH. Risk factors for kidney cancer in New South Wales—I. Cigarette smoking, Eur. J. Cancer, 28A (1992) 2050–2054.

    Google Scholar 

  5. Maclure M. Asbestos and renal adenocarcinoma: a case-control study, Environ. Res., 42 (1987) 353– 361.

    Google Scholar 

  6. Mellemgaard A, Engholm G, McLaughlin JK, and Olsen JH. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors, Int. J. Cancer, 56 (1994) 66–71.

    Article  CAS  PubMed  Google Scholar 

  7. Partanen T, Heikkila P, Hernberg S, Kauppinen T, Moneta G, and Ojajarvi A. Renal cell cancer and occupational exposure to chemical agents, Scand. J. Work. Environ. Health, 17 (1991) 231–239.

    Article  CAS  Google Scholar 

  8. Bruning T, Lammert M, Kempkes M, Thier R, Golka K, and Bolt HM. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene, Arch. Toxicol., 71 (1997) 596–599.

    Article  CAS  PubMed  Google Scholar 

  9. Grawitz P. Die Enstehung von Nierentumoren aus Nebennierengewebe, Arch. Klin. Chir., 30 (1883) 824–834.

    Google Scholar 

  10. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC), Cancer, 80 (1997) 987–989.

    Article  CAS  PubMed  Google Scholar 

  11. Glenn GM, Choyke PL, Zbar B, and Linehan WM. Von Hippel-Lindau disease: clinical review and molecular genetics. In Problems in Urologic Surgery: Benign and Malignant Tumors of the Kidney. Anderson E (ed.), JB Lippincott, Philadelphia, PA, 1990, pp. 312–330.

    Google Scholar 

  12. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, 260 (1993) 1317–1320.

    Article  CAS  PubMed  Google Scholar 

  13. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, and Brown RS. Hereditary renal-cell carcinoma associated with a chromosomal translocation, N. Engl. J. Med., 301 (1979) 592–595.

    Article  CAS  PubMed  Google Scholar 

  14. Li FP, Decker HJ, Zbar B, Stanton VP Jr, Kovacs G, Seizinger BR, et al. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Genetics of familial renal carcinoma, Ann. Intern. Med., 118 (1993) 106–111.

    Article  CAS  PubMed  Google Scholar 

  15. Kovacs G and Hoene E. Loss of der(3) in renal carcinoma cells of a patient with constitutional t(3;12), Hum. Genet., 78 (1988) 148–150.

    Article  CAS  PubMed  Google Scholar 

  16. Zbar B, Tory K, Merino M, Schmidt L, Glenn G, Choyke P, et al. Hereditary papillary renal cell carcinoma, J. Urol., 151 (1994) 561–566.

    CAS  PubMed  Google Scholar 

  17. Zbar B, Glenn G, Lubensky I, Choyke P, Walther MM, Magnusson G, et al. Hereditary papillary renal cell carcinoma: clinical studies in 10 families, J. Urol., 153 (1995) 907–912.

    Article  CAS  PubMed  Google Scholar 

  18. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas, Nat. Genet., 16 (1997) 68–73.

    Article  CAS  PubMed  Google Scholar 

  19. Weirich G, Glenn G, Junker K, Merino M, Storkel S, Lubensky I, et al. Familial renal oncocytoma: clinicopathological study of 5 families, J. Urol., 160 (1998) 335–340.

    Article  CAS  PubMed  Google Scholar 

  20. Harris H, Miller OJ, Klein G, Worst P, and Tachibana T. Suppression of malignancy by cell fusion, Nature, 223 (1969) 363–368.

    Article  CAS  PubMed  Google Scholar 

  21. Stanbridge EJ. Suppression of malignancy in human cells, Nature, 260 (1976) 17–20.

    Article  CAS  PubMed  Google Scholar 

  22. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma, Proc. Natl. Acad. Sci. USA, 68 (1971) 820–823.

    Article  PubMed  Google Scholar 

  23. Knudson AG Jr and Strong LC. Mutation and cancer: a model for Wilms’ tumor of the kidney, J. Natl. Cancer Inst., 48 (1972) 313–324.

    PubMed  Google Scholar 

  24. Bishop JM. The molecular genetics of cancer, Science, 235 (1987) 305–311.

    Article  CAS  PubMed  Google Scholar 

  25. Shi G and Cannizzaro LA. Mapping of 29 YAC clones and identification of 3 YACs spanning the translocation t(3;8)(p14.2;q24.1) breakpoint at 8q24.1 in hereditary renal cell carcinoma, Cytogenet. Cell Genet., 75 (1996) 180–185.

    Article  CAS  Google Scholar 

  26. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, and Brown RS. Hereditary renal-cell carcinoma associated with a chromosomal translocation, N. Engl. J. Med., 301 (1979) 592–595.

    Article  CAS  PubMed  Google Scholar 

  27. Wang N and Perkins KL. Involvement of band 3p14 in t(3; 8) hereditary renal carcinoma, Cancer Genet. Cytogenet., 11 (1984) 479–481.

    Article  CAS  PubMed  Google Scholar 

  28. Kovacs G, Brusa P, and De Riese W. Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas, Int. J. Cancer, 43 (1989) 422–427.

    Article  CAS  PubMed  Google Scholar 

  29. Koolen MI, van der Meyden AP, Bodmer D, Eleveld M, van der Looij E, Brunner H, et al. A familial case of renal cell carcinoma and a t(2;3) chromosome translocation, Kidney Int., 53 (1998) 273–275.

    Article  CAS  PubMed  Google Scholar 

  30. Bodmer D, Eleveld MJ, Ligtenberg MJ, Weterman MAJ, Janssen BAP, Smeets DFCM, et al. An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell carcinoma and a t(2;3) (q35;q21) chromosomal translocation, Am. J. Hum. Genet., 62 (1998) 1475–1483.

    Article  CAS  PubMed  Google Scholar 

  31. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma, Nat. Genet., 7 (1994) 85–90.

    Article  CAS  PubMed  Google Scholar 

  32. Schmidt L, Li F, Brown RS, Berg S, Chen F, Wei MH, et al. Mechanisms of tumorigenesis of renal carcinomas associated with the constitutional 3;8 translocation, Cancer J. Scientif. Am., 1 (1995) 191–195.

    CAS  Google Scholar 

  33. Zbar B, Brauch H, Talmadge C, and Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma, Nature, 327 (1987) 721–724.

    Article  CAS  PubMed  Google Scholar 

  34. Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma, Cancer Res., 51 (1991) 1071–1077.

    CAS  PubMed  Google Scholar 

  35. Yoshida MA, Ohyashiki K, Ochi H, Gibas Z, Pontes JE, Prout GRJ, et al. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma, Cancer Res., 46 (1986) 2139–2147.

    CAS  PubMed  Google Scholar 

  36. Yoshida MA, Ohyashiki K, Ochi H, Gibas Z, Prout GRJ, Pontes EJ, et al. Rearrangement of chromosome 3 in renal cell carcinoma, Cancer Genet. Cytogenet., 19 (1986) 351–354.

    Article  CAS  Google Scholar 

  37. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Muller-Brechlin R, Klein G, and Sumegi J. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma, Proc. Natl. Acad. Sci. USA, 85 (1988) 1571–1575.

    Article  CAS  PubMed  Google Scholar 

  38. Kovacs G and Brusa P. Clonal chromosome aberrations in normal kidney tissue from patients with renal cell carcinoma, Cancer Genet. Cytogenet., 37 (1989) 289, 290.

    Google Scholar 

  39. Kovacs G, Wilkens L, Papp T, and De Riese W. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis, J. Natl. Cancer Inst., 81 (1989) 527–530.

    Article  CAS  PubMed  Google Scholar 

  40. Kovacs G. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases, Am. J. Pathol., 134 (1989) 27–34.

    Google Scholar 

  41. Kovacs G, Fuzesi L, Emanual A, and Kung HF. Cytogenetics of papillary renal cell tumors, Genes. Chromosomes. Cancer, 3 (1991) 249–255.

    Article  CAS  Google Scholar 

  42. Anglard P, Trahan E, Liu S, Latif F, Merino MJ, Lerman MI, et al. Molecular and cellular characterization of human renal cell carcinoma cell lines, Cancer Res., 52 (1992) 348–356.

    CAS  PubMed  Google Scholar 

  43. Lamiell JM, Salazar FG, and Hsia YE. von Hippel-Lindau disease affecting 43 members of a single kindred, Medicine (Baltimore), 68 (1989) 1–29.

    CAS  Google Scholar 

  44. Poston CD, Jaffe GS, Lubensky IA, Solomon D, Zbar B, Linehan WM, and Walther MM. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von HippelLindau disease: clinical and molecular genetic implications, J. Urol., 153 (1995) 22–26.

    Article  CAS  PubMed  Google Scholar 

  45. Marshall M. von Hippel-Lindau’s disease: analysis of age of onset and gene expression in a human genetic disease, MS Thesis, 1979.

    Google Scholar 

  46. Neumann HP, Eggert HR, Scheremet R, Schumacher M, Mohadj er M, Wakhloo AK, et al. Central nervous system lesions in von Hippel-Lindau syndrome, J. Neurol. Neurosurg. Psychiatry, 55 (1992) 898–901.

    Article  CAS  PubMed  Google Scholar 

  47. Walther MM, Choyke PL, Weiss G, Manolatos C, Long J, Reiter R, et al. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma, J. Urol., 153 (1995) 913–916.

    Article  CAS  PubMed  Google Scholar 

  48. Walther MM, Choyke PL, Glenn GM, Lyne JC, Rayford W, Venzon D, and Linehan WM. Renal cancers in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery, J. Urol., 161 (1999) 1475–1479.

    Article  CAS  PubMed  Google Scholar 

  49. Walther MM, Thompson N, and Linehan W. Enucleation procedures in patients with multiple hereditary renal tumors, World J. Urol., 13 (1995) 248–250.

    CAS  Google Scholar 

  50. Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma, Nature, 332 (1988) 268–269.

    Article  CAS  PubMed  Google Scholar 

  51. Lerman MI, Latif F, Glenn GM, Daniel LN, Brauch H, Hosoe S, et al. Isolation and regional localization of a large collection (2,000) of single-copy DNA fragments on human chromosome 3 for mapping and cloning tumor suppressor genes, Hum. Genet., 86 (1991) 567–577.

    CAS  Google Scholar 

  52. Hosoe S, Brauch H, Latif F, Glenn G, Daniel L, Bale S, et al. Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3, Genomics, 8 (1990) 634–640.

    Article  CAS  PubMed  Google Scholar 

  53. Tory K, Brauch H, Linehan M, Barba D, Oldfield E, Filling-Katz M, et al. Specific genetic change in tumors associated with von Hippel-Lindau disease, J. Natl. Cancer Inst., 81 (1989) 1097–1101.

    Article  CAS  PubMed  Google Scholar 

  54. Kuzmin I, Stackhouse T, Latif F, Duh FM, Geil L, Gnarra J, et al. One-megabase yeast artificial chromosome and 400-kilobase cosmid-phage contigs containing the von hippel-lindau tumor suppressor and Ca(2+)-transporting adenosine triphosphatase isoform 2 genes, Cancer Res., 54 (1994) 2486–2491.

    CAS  PubMed  Google Scholar 

  55. Yao M, Latif F, Kuzmin I, Stackhouse T, Zhou FW, Tory K, et al. Von Hippel-Lindau disease: identification of deletion mutations by pulsed field gel electrophoresis, Hum. Genet., 92 (1993) 605–614.

    CAS  Google Scholar 

  56. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, et al. Germline mutations in the von HippelLindau disease tumor suppressor gene: correlations with phenotype, Hum. Mutat., 5 (1995) 66–75.

    Article  CAS  Google Scholar 

  57. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinoma, Cancer Res., 54 (1994) 2852–2855.

    CAS  PubMed  Google Scholar 

  58. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype, Hum. Mol. Genet., 3 (1994) 1303–1308.

    CAS  Google Scholar 

  59. Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, et al. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p 5q 1 1p 17 and 22, Br. J. Cancer, 69 (1994) 230–234.

    Article  CAS  PubMed  Google Scholar 

  60. Bailly M, Bain C, Favrot MC, and Ozturk M. Somatic mutations of von Hippel-Lindau (VHL) tumor supressor gene in European kidney cancers, Int. J. Cancer, 63 (1995) 660–664.

    Article  CAS  PubMed  Google Scholar 

  61. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, et al. Germ-line mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma, Am. J. Hum. Genet., 55 (1994) 1092–1102.

    CAS  PubMed  Google Scholar 

  62. Glavac D, Ravnik-Glavac M, Ovcak Z, and Masera A. Genetic changes in the origin and development of renal cell carcinoma (RCC), Pflugers Arch., 431 (1996) R193–R194.

    Article  CAS  PubMed  Google Scholar 

  63. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma, Proc. Natl. Acad. Sci. USA, 91 (1994) 9700–9704.

    Article  CAS  PubMed  Google Scholar 

  64. Bird AP. CpG-rich islands and the function of DNA methylation, Nature, 321 (1986) 209–213.

    Article  CAS  PubMed  Google Scholar 

  65. Knudson AG Jr. VHL Gene mutation and clear-cell renal carcinomas, Cancer J. Scientif. Am., 1 (1995) 1801–1805.

    Google Scholar 

  66. Presti JC Jr, Moch H, Reuter VE, Cordon-Cardo C, and Waldman FM. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis, J. Urol., 156 (1996) 281–285.

    Article  CAS  PubMed  Google Scholar 

  67. Kenck C, Bugert P, Wilhelm M, and Kovacs G. Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas, Oncogene, 14 (1997) 1093–1098.

    Article  CAS  PubMed  Google Scholar 

  68. Kovacs G and Frisch S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas, Cancer Res., 49 (1989) 651–659.

    CAS  PubMed  Google Scholar 

  69. Kovacs G, Emanuel A, Neumann HP, and Kung HF. Cytogenetics of renal cell carcinomas associated with von Hippel- Lindau disease, Genes. Chromosomes. Cancer, 3 (1991) 256–262.

    Article  CAS  Google Scholar 

  70. Kovacs G. Molecular cytogenetics of renal cell tumors, Adv. Cancer Res., 62 (1993) 89–124.

    Article  CAS  Google Scholar 

  71. Dijkhuizen T, van den Berg E, van den Berg A, Van De Veen A, Dam A, Faber H, et al. Genetics as a diagnostic tool in sarcomatoid renal-cell cancer, Int. J. Cancer, 72 (1997) 265–269.

    Article  CAS  PubMed  Google Scholar 

  72. Gannon JV, Greaves R, Iggo R, and Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form, EMBO J., 9 (1990) 1595–1602.

    CAS  PubMed  Google Scholar 

  73. Levine AJ, Momand J, and Finlay CA. The p53 tumour suppressor gene, Nature, 351 (1991) 453–456.

    Article  CAS  PubMed  Google Scholar 

  74. Suzuki Y, Tamura G, Satodate R, and Fujioka T. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis, Jpn. J. Cancer Res., 83 (1992) 233–235.

    CAS  Google Scholar 

  75. Presti JC Jr, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR, and Jhanwar SC. Allelic deletions in renal tumors: histopathological correlations, Cancer Res., 53 (1993) 5780–5783.

    CAS  PubMed  Google Scholar 

  76. Reiter RE, Anglard P, Liu S, Gnarra JR, and Linehan WM. Chromosome 17p deletions and p53 mutations in renal cell carcinoma, Cancer Res., 53 (1993) 3092–3097.

    CAS  PubMed  Google Scholar 

  77. Oda H, Nakatsuru Y, and Ishikawa T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas, Cancer Res., 55 (1995) 658–662.

    CAS  PubMed  Google Scholar 

  78. Wu SQ, Hafez GR, Xing W, Newton M, Chen XR, and Messing E. The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with non-papillary renal cell carcinoma, Cancer, 77 (1996) 1154–1160.

    Article  CAS  PubMed  Google Scholar 

  79. Decker HJ, Neuhaus C, Jauch A, Speicher M, Ried T, Bujard M, et al. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH, Hum. Genet., 97 (1996) 770–776.

    CAS  Google Scholar 

  80. Suzuki H, Ueda T, Komiya A, Okano T, Isaka S, Shimazaki J, and Ito H. Mutational state of von HippelLindau and adenomatous polyposis coli genes in renal tumors, Oncology, 54 (1997) 252–257.

    Article  CAS  PubMed  Google Scholar 

  81. Kovacs G. Molecular differential pathology of renal cell tumours, Histopathology, 22 (1993) 1–8.

    Article  CAS  PubMed  Google Scholar 

  82. Thoenes W, Storkel S, and Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas, and carcinomas). The basic cytological and histopathological elements and their use for diagnostics, Pathol. Res. Pract., 181 (1986) 125–143.

    Article  CAS  Google Scholar 

  83. Mancilla-Jimenez R, Stanley RJ, and Blath RA. Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases, Cancer, 38 (1976) 2469–2480.

    Article  CAS  PubMed  Google Scholar 

  84. Delahunt B and Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors, Mod. Pathol., 10 (1997) 537–544.

    CAS  Google Scholar 

  85. Guinan PD, Vogelzang NJ, Fremgen AM, Chmiel JS, Sylvester JL, Sener SF, and Imperato JP. Renal cell carcinoma: tumor size, stage and survival. Members of the Cancer Incidence and End Results Committee, J. Urol., 153 (1995) 901–903.

    Article  CAS  PubMed  Google Scholar 

  86. Kovacs G. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours, World J. Urol., 12 (1994) 64–68.

    CAS  Google Scholar 

  87. Ishikawa I and Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis, Histopathology, 22 (1993) 135–139.

    Article  CAS  PubMed  Google Scholar 

  88. Hughson MD, Schmidt L, Zbar B, Daugherty S, Meloni AM, Silva FG, and Sandberg AA. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study, J. Am. Soc. Nephrol., 7 (1996) 2461–2468.

    CAS  PubMed  Google Scholar 

  89. Schmidt L, Junker K, Weirich G, Glenn G, Choyke P, Lubensky I, et al. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene, Cancer Res., 58 (1998) 1719–1722.

    CAS  PubMed  Google Scholar 

  90. Zhuang Z, Park W, Pack S, Schmidt L, Vortmeyer AO, Pak E, et al. Trisomy 7-harbouring non-random duplication of the mutant met allele in hereditary papillary renal carcinomas, Nat. Genet., 1998, (in press).

    Google Scholar 

  91. Herring JC, Schmetz MA, Digan AB, Young ST, and Kalloo NB. Renal medullary carcinoma: a recently described highly aggressive renal tumor in young black patients, J. Urol., 157 (1997) 2246, 2247.

    Google Scholar 

  92. Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin PB, and Reuter VE. Renal oncocytoma: a clinicopathologic study of 70 cases, Am. J. Surg. Pathol., 21 (1997) 871–883.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Erik Enquist
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norman Zambrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Burton Zbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Marston Linehan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. McClellan M. Walther
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Experimental Therapeutics, Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA

    Ronald M. Bukowski MD (Director) (Director)

  2. Department of Urology, Cleveland Clinic Foundation, Cleveland, OH, USA

    Andrew C. Novick MD (Chairman) (Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Enquist, E., Zambrano, N., Zbar, B., Linehan, W.M., Walther, M.M. (2000). Molecular Genetics of Renal Cell Carcinoma. In: Bukowski, R.M., Novick, A.C. (eds) Renal Cell Carcinoma. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-229-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-229-6_5

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6401-7

  • Online ISBN: 978-1-59259-229-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation